Product Reports Resources Pricing Login Book a demo

Curebay

Biotech & Life Sciences · Bhubaneswar Municipal Corporation, India · Founded 2021

On a mission to bridge the healthcare gap in the Indian healthcare system MoreLess

Curebay is a health-tech company established in 2020 and officially incorporated in December of that year, with operations beginning in 2021. The company was founded by Priyadarsi Mohapatra, Shobhan Mahapatra, and Sanjay Swain, who were motivated by the healthcare disparities between urban and rural India that became evident during the COVID-19 pandemic. The founders leverage extensive experience from the technology and consumer sectors. CEO Priyadarsi Mohapatra previously held leadership roles at Google, Microsoft, and SAP and co-founded a venture-capital-funded jewelry chain, Oyzterbay, which was later acquired. Co-founder Shobhan Mahapatra brings over two decades of experience from the manufacturing and IT service sectors, including a role as CIO at Birlasoft. Co-founder and CTO Sanjay Swain has a deep background in technology, with previous positions at Nielsen, TIBCO Software, and Tata Consultancy Services.

Curebay operates on a hybrid 'phygital' model designed to provide accessible and affordable healthcare to underserved populations in rural and semi-urban India. The business structure is a hub-and-spoke network, consisting of satellite e-clinics that connect patients in remote areas with healthcare providers digitally. This model addresses the significant gap in primary healthcare by reducing the need for patients to travel long distances to urban centers for quality medical attention. The company targets individuals and families in these regions who face barriers to accessing medical services due to limited infrastructure and a shortage of local specialists. Revenue is generated through the provision of these healthcare services.

The company's platform offers a comprehensive suite of services. These include scheduling doctor appointments, facilitating teleconsultations, delivering medicine, and managing diagnostic testing needs. A key feature is a concierge service that assists patients with admission to tertiary care at partner hospitals, ensuring support from admission to discharge. Through its network of over 100 e-clinics primarily in Odisha and Chhattisgarh, Curebay has provided services to more than 175,000 patients. To fuel its expansion, the company has successfully raised significant capital, including a Series A round and a $21 million Series B round in May 2025, with major investors like Elevar Equity and Bertelsmann India Investments.

Keywords: health-tech, rural healthcare India, telemedicine, e-clinics, phygital healthcare, primary healthcare, healthcare accessibility, medical services delivery, diagnostics, teleconsultation, online pharmacy, hospital concierge, Priyadarsi Mohapatra, Shobhan Mahapatra, Sanjay Swain, Elevar Equity, Bertelsmann India Investments, healthcare logistics, underserved markets, affordable healthcare

Company overview

Curebay company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2021
Headquarters
Bhubaneswar Municipal Corporation, India
Employees
72
Open positions
1
Dealroom signal
57.6
client focusb2bclient focusb2csub industryPharmaceuticalsub industryHealth Platformbusiness modelMarketplace & ecommercesectorHealthcare ServicessectorElectronic Health Records (EHR)industryHealthsectorBiotechnologysectorTelemedicinesectorMobile ClinicssectorBiotech and Pharma

Valuation & funding

Curebay funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCEquity / VC Aug 2026 $0 VentureSoul Partners
SERIES BEquity / VC May 2025 $21M $84M Elevar Equity · Bertelsmann Investments · British International Investment
SERIES AEquity / VC Jan 2024 $7.5M $30M Elevar Equity
SERIES AEquity / VC Nov 2022 $6.2M $25M Elevar Equity
Showing 4 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 72
2025 72
2024 72
2023 72
2022 31
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Curebay website traffic

Latest recorded traffic for Curebay is 19K monthly website visits, down 53.7% over the last three months. Curebay's team grew 0% over the past year.

Latest monthly visits19K 3-month web change-53.7% 1-year team growth0%
Monthly website visits44 observations · Nov 2022–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Hiring

Open positions at Curebay

Current openings linked to this company in Dealroom.

1 distinct opening shownExplore hiring signals →

Comparisons

Curebay compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Curebay's talent

Book a demo to see the people
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

5 investors on Curebay's cap table

Sourced from Dealroom's funding and investor records.

Series A 3 investors entered at this stage
Elevar Equity
Bertelsmann Investments
British International Investment
Series B+ 1 investor entered at this stage
VentureSoul Partners
Other known 1 additional known investor
Stride Ventures

Global footprint

Where Curebay has talent and traffic

Workforce by country
3 countries with
team presence
🇮🇳 India98.9%
🇰🇷 South Korea0.5%
🇺🇸 United States0.5%
3 countries shown

In the news

Latest news about Curebay

Recent press, funding announcements, and product moves mentioning Curebay — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Curebay

An AI-synthesized read of the highest-engagement posts about Curebay on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Curebay’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.